Cargando…
Prevalence and Risk Factors of Dyslipidemia among Type 2 Diabetes Patients at a Referral Hospital, North Eastern Ethiopia
BACKGROUND: The prevalence of diabetes and its associated complications rising in Ethiopia ranged from 2.0%–6.5%, the primary cause of morbidity and mortality with consequential economic impact. This study aimed to assess the prevalence and risk factors of dyslipidemia among diabetes follow-up patie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Publications Office of Jimma University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968374/ https://www.ncbi.nlm.nih.gov/pubmed/35392337 http://dx.doi.org/10.4314/ejhs.v31i6.23 |
Sumario: | BACKGROUND: The prevalence of diabetes and its associated complications rising in Ethiopia ranged from 2.0%–6.5%, the primary cause of morbidity and mortality with consequential economic impact. This study aimed to assess the prevalence and risk factors of dyslipidemia among diabetes follow-up patients. METHODS: Institution-based cross-sectional study was conducted at Debre Berhan Referral Hospital from January to March 2020 in 347 Adult type 2 diabetes follow-up patients using a convenient sampling technique. Data were collected by interviews and entered using Epi-data 4.2 and analyzed using SPSS version 25. Factors having a p-value < 0.25 in the bi-variable logistic regression model were entered into a multivariable logistic regression model. Statistical Significance was declared at a p-value ≤ of 0.05. RESULTS: The prevalence of dyslipidemia among type 2 diabetes patients in this study was 59 %. Significantly associated variables were being female [AOR 2.6 (95% CI 1.2–3.2), P = 0.011], smoking history [AOR 4.1 (95% CI 2–6.8), P = 0.001], Being overweight [AOR 3.5 (95% CI 1.6–7.8), P = 0.002], Being obese [AOR 4.8 (95% CI 1.7–13), P = 0.002]. CONCLUSION: Prevalence of dyslipidemia was high among diabetic patients, which accounts for 59%. Being female, smoking history, being overweight, and being obese were determinants of dyslipidemia. Patients with poor glycemic control need additional lipid-lowering therapies to prevent secondary Atherosclerotic vascular complications. |
---|